牙周医生与口腔颌面外科医生对干细胞骨再生治疗的认知与态度调查
该研究通过匿名问卷调查美国牙周学会481名成员(应答率19.41%)和口腔颌面外科医师协会540名成员(应答率21.86%),比较两组对干细胞骨移植治疗的认知、兴趣与看法。
要点
- 牙周医生与颌面外科医生均认为干细胞骨移植有前景,并倾向优于传统方法。
- 两组最看重该疗法能加速愈合且产出更多更优质骨组织。
- 牙周医生更愿通过面授课程学习,颌面外科医生更倾向在线课程(P < .001)。
核心结论
- 牙周医生与口腔颌面外科医生均对干细胞骨移植治疗持积极态度,认为其有前景并偏好优于传统方法。
- 研究结果为针对临床医生开发教育干预措施及未来研究方向提供了依据。
研究设计与样本
- 匿名问卷调查美国牙周学会481名成员(应答率19.41%)与口腔颌面外科医师协会540名成员(应答率21.86%)。
- 比较两组对干细胞骨移植治疗的认知、兴趣与看法。
主要发现
- 更多牙周医生主要通过出版物听说过干细胞骨移植(P < .001)。
- 牙周医生更感兴趣通过面授继续教育课程学习,颌面外科医生更感兴趣通过在线继续教育课程学习(P < .001)。
- 两组均认为干细胞骨移植有前景并偏好优于传统方法,最看重加速愈合且质量更优。
- 该疗法可接受的最高费用范围为35美元至5000美元;两组多数受访者认为患者可能或很可能偏好该疗法。
临床怎么用
- 临床医生应关注干细胞骨移植治疗在口腔颌面重建中的潜力,并参与相关继续教育。
- 针对牙周医生可优先提供面授课程,针对颌面外科医生可优先提供在线课程。
局限性
- 问卷应答率牙周组为19.41%、颌面外科组为21.86%,可能存在无应答偏倚。
- 仅调查了骨移植在执业中的比例,其他服务比例未纳入调查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although stem cell therapies are now used in medicine, they have not yet been approved in dentistry. The authors compared periodontists' and oral maxillofacial surgeons' (OMSs) knowledge, interests, and thoughts about the adoption of stem cell-based therapy for use in oral and craniofacial reconstructive procedures. METHODS: Anonymous survey data were collected from 481 members of the American Academy of Periodontology (response rate, 19.41%) and from 540 members of the American Association of Oral and Maxillofacial Surgeons (response rate, 21.86%). RESULTS: Twenty-four percent of the practice of periodontists and 14% of the practice of OMSs consisted of bone grafting procedures (P < .001); the other proportions of services these practices rendered were not surveyed. More periodontists than OMSs had heard about stem cell-based bone grafting from publications mainly (P < .001). Periodontists were more interested to learn about this approach via in-person continuing education courses and OMSs were more interested to learn via online continuing education courses (P < .001). Both groups considered stem cell-based bone grafting promising and indicated they would prefer it to traditional approaches. Most important to both groups was that this approach would yield more and better quality in accelerated healing. The highest acceptable cost for this therapy ranged from $35 through $5,000. Most of the respondents in both groups thought it was likely or very likely that patients would prefer it. CONCLUSIONS: These findings provide a basis for developing educational interventions for clinicians and informing future research activities addressing providers' questions about stem cell-based therapies. PRACTICAL IMPLICATIONS: The authors underscored the interest in clinical adoption of stem cell-based therapies for oral and craniofacial conditions.
引用
- Kaigler D, Misch JE, Aronovich S, et al. Stem cell-based therapy for bone regeneration: Periodontists' and oral maxillofacial surgeons' considerations. J Am Dent Assoc. 2026. PMID: 41984010. doi:10.1016/j.adaj.2025.12.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。